BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.

Leadership is about driving change at scale and requires engaging both hearts and minds. Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights ...

Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value. The ex-Pfizer executives, Ian Read and ...

Pfizer is making these changes in preparation for integrating Seagen once the $43 billion merger closes, expected in late 2023 or early 2024. For now, the two companies are operating independently ...

In 2020, Bourla took over as chairman of the board. In its proxy, Pfizer said it backed the board’s “leadership structure” after a review in December.